Fulkerson Daniel E, Heck Abigail, Hauser Natalie, Fulkerson Daniel H
Washington University School of Medicine, St. Louis, Missouri, USA.
Beacon Children's Hospital, Beacon Medical Group North Central Neurosurgery, South Bend, Indiana, USA.
Pediatr Neurosurg. 2025;60(1-2):32-37. doi: 10.1159/000545882. Epub 2025 Apr 15.
Pineal parenchymal tumors of intermediate differentiation (PPTIDs) are rare, pinealocyte-derived brain tumors that occur primarily in adults. The clinical prognosis fits somewhere between the benign pineocytoma and highly malignant pineoblastoma. There is very little published literature regarding this tumor in children and the existing pediatric information is enfolded with adult data in single-center reviews. The most common treatment recommendation for adults is aggressive resection, possibly followed by craniospinal irradiation (CSI) and/or chemotherapy. However, the adult literature is inconsistent, often contradictory, and does not address specific considerations in pediatric patients. To our knowledge, there are no papers specifically addressing the management and clinical considerations of PPTID in pediatric patients. As such, the optimal treatment strategy in children is unknown.
We describe the treatment of a 6-year-old child who presented with obstructive hydrocephalus from a PPTID. The child was treated with a partial tumor resection followed by localized proton beam radiation. He has been followed for 8 years. Clinically, he is doing well, and his most recent MRI shows negligible residual tumor with no sign of recurrence.
Our case suggests safe resection followed by proton beam radiotherapy may be effective in treating children with this exceedingly rare entity. While further study is needed, this strategy may avoid unnecessary surgical risk and the consequences of CSI on the developing pediatric nervous system.
间变性松果体实质肿瘤(PPTIDs)是一种罕见的、起源于松果体细胞的脑肿瘤,主要发生于成年人。其临床预后介于良性松果体细胞瘤和高度恶性松果体母细胞瘤之间。关于儿童该肿瘤的已发表文献非常少,现有的儿科信息在单中心综述中与成人数据混杂在一起。对于成年人,最常见的治疗建议是积极切除肿瘤,术后可能需要进行全脑全脊髓放疗(CSI)和/或化疗。然而,成人相关文献并不一致,常常相互矛盾,且未涉及儿科患者的特殊注意事项。据我们所知,尚无专门针对儿科患者PPTID的管理和临床注意事项的论文。因此,儿童的最佳治疗策略尚不清楚。
我们描述了一名6岁儿童的治疗情况,该儿童因PPTID导致梗阻性脑积水。患儿接受了部分肿瘤切除术,随后进行了局部质子束放疗。我们对其进行了8年的随访。临床上,他情况良好,最近的MRI显示残留肿瘤可忽略不计,且无复发迹象。
我们的病例表明,安全切除肿瘤后进行质子束放疗可能对治疗患有这种极其罕见疾病的儿童有效。虽然还需要进一步研究,但这种策略可能避免不必要的手术风险以及CSI对发育中的儿科神经系统的影响。